APOBEC3B and liver cancer: explored how APOBEC3B promotes the upregulation of chemokine expression and thus the recruitment of MDSCs and TAMs to promote the occurrence and development of liver cancer; they reviewed previous studies and found that chemokine expression is regulated by genetic and epigenetic mechanisms inherent in cancer, such as DNA methylation and polycomb repressive complex 2 (PRC 2) (82).